EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracorporeal membrane oxygenation in children with cancer

A. Y. Ivanashkin, P. E. Dyakonov, E. A. Ryadinskaya, I. A. Kryukov, V. V. Lazarev, I. G. Khamin, A. A. Maschan, G. A. Novichkova, D. G. Akhaladze, D. N. Arzin, N. V. Myakova, V. V. Shchukin und 2 weitere

Pediatric Hematology/Oncology and Immunopathology · 14.04.2026 · 25 (1) · 54-59

DOI: 10.24287/j.1002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Hematology/Oncology and Immunopathology, online erschienen am 14.04.2026. Verfasst von A. Y. Ivanashkin und 13 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Extracorporeal membrane oxygenation (ECMO) is increasingly used in pediatric oncology patients with severe cardiac and/or respiratory failure. However, experience with this technique in this population remains limited, particularly in Russia. Materials and methods. Here we retrospectively reviewed the first 5 cases of peripheral venoarterial ECMO use in children with malignancies (4 females, 1 male) treated at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology from October 2024 to May 2025. The median age was 12 years. Indications, patient selection criteria, ECMO duration, complications, and outcomes were analyzed.

Results

In 4 out of 5 patients, ECMO was initiated due to refractory cardiac and/or respiratory failure, and in 1 case, it was used as intraoperative support. The median ECMO duration was 5 days; the median length of stay at the Intensive Care Unit was 20 days. Four patients were successfully decannulated and subsequently discharged. One patient died due to oxygenator thrombosis. Despite the extreme illness severity at baseline (pSOFA 9, VIS 95, VVR 112), no major infectious or hemorrhagic complications occurred.

Conclusion

In this paper, we reported the first Russian experience of ECMO use in children with cancer demonstrating that not only is it in principle possible but also effective, as long as a multidisciplinary approach and strict selection criteria are adopted and a trained team of specialists are on hand.

Zitieren

APA

Ivanashkin, A. Y., Dyakonov, P. E., Ryadinskaya, E. A., Kryukov, I. A., Lazarev, V. V., Khamin, I. G., Maschan, A. A., Novichkova, G. A., Akhaladze, D. G., Arzin, D. N., Myakova, N. V., Shchukin, V. V., Makhalin, M. V., & Grachev, N. S. (2026). Extracorporeal membrane oxygenation in children with cancer. Pediatric Hematology/Oncology and Immunopathology, 25(1), 54-59. https://doi.org/10.24287/j.1002

Vancouver

Ivanashkin AY, Dyakonov PE, Ryadinskaya EA, Kryukov IA, Lazarev VV, Khamin IG, et al. Extracorporeal membrane oxygenation in children with cancer. Pediatric Hematology/Oncology and Immunopathology. 2026;25(1):54-59. doi:10.24287/j.1002

BibTeX
@article{Ivanashkin2026,
  author = {Ivanashkin, A. Y. and Dyakonov, P. E. and Ryadinskaya, E. A. and Kryukov, I. A. and Lazarev, V. V. and Khamin, I. G. and Maschan, A. A. and Novichkova, G. A. and Akhaladze, D. G. and Arzin, D. N. and Myakova, N. V. and Shchukin, V. V. and Makhalin, M. V. and Grachev, N. S.},
  title = {Extracorporeal membrane oxygenation in children with cancer},
  journal = {Pediatric Hematology/Oncology and Immunopathology},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {54--59},
  doi = {10.24287/j.1002}
}
Kostenlos starten →